Identification and Experimental Validation of Tumor Antigens and Hypoxia Subtypes of Osteosarcoma for Potential mRNA Vaccine Development
This study identified potential antigens for the anti-OS mRNA vaccine as well as different OS hypoxia subtypes, guiding more effective immunotherapeutic strategies and selecting appropriate patients for tumor vaccine therapy.
Authors
- Chunnian Ren
- Dawei He (ORCID: https://orcid.org/0000-0002-1695-5886)
- Quan Wang (ORCID: https://orcid.org/0009-0007-4729-7621)
Institutions
- University of Electronic Science and Technology of China (CN)
- China International Science and Technology Cooperation (CN)
- Chengdu Women's and Children's Central Hospital (CN)
- Children's Hospital of Chongqing Medical University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Current Medicinal Chemistry
- Published
- 2025-04-29
- DOI
- https://doi.org/10.2174/0109298673348041250407062346
- Citations
- 3
- Primary Topic
- RNA Interference and Gene Delivery
- Type
- article
- Field-Weighted Citation Impact
- 2.42